Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Oct 21, 2022

SELL
$0.13 - $76.84 $300 - $177,730
-2,313 Reduced 32.57%
4,789 $340,000
Q2 2022

Jul 20, 2022

BUY
$72.62 - $79.98 $285,687 - $314,641
3,934 Added 124.18%
7,102 $547,000
Q1 2022

Apr 26, 2022

BUY
$61.48 - $73.72 $194,768 - $233,544
3,168 New
3,168 $231,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $120B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Center For Asset Management LLC Portfolio

Follow Center For Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Center For Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Center For Asset Management LLC with notifications on news.